Cargando…
Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker
BACKGROUND: Chronic graft-versus-host disease (cGvHD) is a major complication after allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) is an immunotherapy treatment for cGvHD, although suitable response biomarkers are lacking. MATERIALS & METHODS: We analyzed data...
Autores principales: | Lopes, Sérgio Machado, Roncon, Susana, Pinho, Ana Catarina, Bordalo, Filipa, Antunes, Luís, Campilho, Fernando, Campos, António, Costa-Pereira, Altamiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491011/ https://www.ncbi.nlm.nih.gov/pubmed/32983569 http://dx.doi.org/10.2144/fsoa-2020-0107 |
Ejemplares similares
-
Extracorporeal Photopheresis—An Overview
por: Cho, Ara, et al.
Publicado: (2018) -
Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
por: Roberto, Crocchiolo, et al.
Publicado: (2021) -
Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
por: Kozlov, Andrey, et al.
Publicado: (2021) -
Guidelines on the use of extracorporeal photopheresis
por: Knobler, R, et al.
Publicado: (2014) -
Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
por: Crocchiolo, Roberto, et al.
Publicado: (2021)